Additionally, our in-silico analysis of NSCLC miRNA conducted using the public Gene Expression Omnibus (GEO; GSE102286) database demonstrated that the expression of hsa-miR-497, which predictively targets the expression of SREBP-1, was significantly inhibited in our tumor samples. Here, SREBF1 is linked to non-small cell lung carcinoma.